Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.
Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 26, 2021 | e therapeutics : Interim Results, July 2021 and RNAi Platform Development Presentation | Integrating computational power and biology to discover life-transforming medicines Interim results for six months ended 31 July 2021 Successful RNAi Platform Development October 2021 1 Legal Disclaimer Forward looking statement This docume... |
| Oct 26, 2021 | e therapeutics : Interim results for six months ended 31 July 2021 | e-therapeutics plc ("e-therapeutics" or the "Company") Interim results for six months ended 31 July 2021 Significantly strengthened cash position to facilitate a number of initiatives, expanding the Company's platform ca... |
| Oct 26, 2021 | e therapeutics : RNAi Platform Characterisation Results | News & Media - e-therapeutics plc ("e-therapeutics" or the "Company") RNAi Platform Characterisation Results Oxford, UK, 26 October 2021 - e-therapeutics plc (AIM: ETX; OTCQX: ETXPF), a specialist in computational dr... |
| Oct 11, 2021 | e therapeutics : Patent Filings – October 2021 | e-therapeutics plc ("e-therapeutics" or the "Company") Patent Filing Applications Further advancement in the Company's RNAi Platform Development Oxford, UK, 11 October 2021 - e-therapeutics plc (AIM: ETX; OTCQX; ETXPF), ... |
| Sep 24, 2021 | e therapeutics : Commencement of trading on the OTCQX Best Market in the United States | e-therapeutics plc ("e-therapeutics" or the "Company") Commencement of trading on the OTCQX Best Market in the United States Oxford, UK, 24 September 2021 - e-therapeutics plc (AIM: ETX; OTCQX; ETXPF), a specialist in co... |
| Jul 6, 2021 | e therapeutics : Director Dealing and Issue of Equity | e-therapeutics plc ("e-therapeutics" or "the Company") Director Dealing and Issue of Equity Oxford, UK, 6 July 2021 - e-therapeutics plc (AIM: ETX) announces that on 6 July 2021, Professor Trevor Jones, Non-Executive Cha... |
| Jul 2, 2021 | e therapeutics : Further milestone in Galapagos collaboration | e-therapeutics plc ("e-therapeutics" or "the Company") Achievement of further milestone in Galapagos collaboration Oxford, UK, 2 July 2021 - e-therapeutics plc (AIM: ETX.L) announces that it has met a key milestone in it... |
| May 21, 2021 | E-THERAPEUTICS PLC e therapeutics : Annual Report for the year ended 31 January 2021 | Accelerating the path to better therapies Annual Report 2021 We Construct in-silico Models of Biological Functions We Identify Novel Targets and Mechanisms We Design Novel Small Molecules and RNAi Therapeutics Strategic Report 01 Highlights... |
| May 21, 2021 | E-THERAPEUTICS PLC e therapeutics : Notice of Annual General Meeting and Posting of Annual Report and Accounts | e-therapeutics plc ("e-therapeutics" or "the Company") Notice of Annual General Meeting and Posting of Annual Report and Accounts Oxford, 21 May 2021 - e-therapeutics plc (AIM: ETX), the drug discovery company, announces... |
Reviews 0
FAQ about e-therapeutics PLC
When was e-therapeutics PLC founded?
e-therapeutics PLC was founded in 2001.
What has the press written about e-therapeutics PLC?
Parsers VC has collected 17 articles mentioning e-therapeutics PLC, among them “e therapeutics : Interim Results, July 2021 and RNAi Platform Development Presentation” (Oct 26, 2021) and “e therapeutics : Interim results for six months ended 31 July 2021” (Oct 26, 2021).
Is e-therapeutics PLC still active?
Yes, e-therapeutics PLC is active; its latest activity on Parsers VC dates from Oct 26, 2021.